Role of cytochrome P450 in drug interactions
Open Access
- 18 October 2008
- journal article
- retracted article
- Published by Springer Science and Business Media LLC in Nutrition & Metabolism
- Vol. 5 (1), 27
- https://doi.org/10.1186/1743-7075-5-27
Abstract
Drug-drug interactions have become an important issue in health care. It is now realized that many drug-drug interactions can be explained by alterations in the metabolic enzymes that are present in the liver and other extra-hepatic tissues. Many of the major pharmacokinetic interactions between drugs are due to hepatic cytochrome P450 (P450 or CYP) enzymes being affected by previous administration of other drugs. After coadministration, some drugs act as potent enzyme inducers, whereas others are inhibitors. However, reports of enzyme inhibition are very much more common. Understanding these mechanisms of enzyme inhibition or induction is extremely important in order to give appropriate multiple-drug therapies. In future, it may help to identify individuals at greatest risk of drug interactions and adverse events.Keywords
This publication has 145 references indexed in Scilit:
- Systemic Antifungal AgentsDrug Safety, 1998
- Drug Interactions with Proton Pump InhibitorsDrug Safety, 1997
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Drug Interactions with Antiviral DrugsClinical Pharmacokinetics, 1996
- Macrolide AntibacterialsDrug Safety, 1995
- Clinically Significant Drug Interactions with Antituberculosis AgentsDrug Safety, 1994
- The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and NomenclatureDNA and Cell Biology, 1993
- Drug Interactions of Clinical Significance with Opioid AnalgesicsDrug Safety, 1993
- Pharmacokinetic Drug Interactions with Oral ContraceptivesClinical Pharmacokinetics, 1990
- Drug Interactions with CimetidineClinical Pharmacokinetics, 1982